Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
EZN-4176
print preview
bookmark
share with colleague
General Information
Company
Santaris Pharma A/S
Description
Androgen receptor locked nucleic acid (LNA) antisense oligonucleotide (LNA-ON)
Molecular Target
Androgen receptor
Mechanism of Action
Latest Stage of Development
Phase I
Indication
Prostate cancer
Partner
Enzon Pharmaceuticals Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy